NDC 36590-6461

Vonaflex

Lidocaine Lotion

Vonaflex is a Cutaneous; Rectal; Topical; Vaginal Lotion in the Human Otc Drug category. It is labeled and distributed by Cymbiotics, Inc. The primary component is Lidocaine.

Product ID36590-6461_dd30ccaf-d23a-9d82-e053-2a95a90a6e84
NDC36590-6461
Product TypeHuman Otc Drug
Proprietary NameVonaflex
Generic NameLidocaine Lotion
Dosage FormLotion
Route of AdministrationCUTANEOUS; RECTAL; TOPICAL; VAGINAL
Marketing Start Date2022-08-25
Marketing CategoryOTC MONOGRAPH FINAL /
Application NumberM015
Labeler NameCymbiotics, Inc
Substance NameLIDOCAINE
Active Ingredient Strength4 g/100g
Pharm ClassesAmide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 36590-6461-3

100 g in 1 BOTTLE, PUMP (36590-6461-3)
Marketing Start Date2022-08-26
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Vonaflex]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VONAFLEX
VONAFLEX
98382654 not registered Live/Pending
Optimal Laboratories
2024-01-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.